Embecta Health (EMBC) Enterprise Value to EBITDA Ratio
Embecta Corp. is optimizing logistics and clinical trials through external partners while supporting diabetes centers. The company aims to maintain global leadership in the insulin needle segment by developing automation to drive profit growth. Supply security is guaranteed by delegating plastic molding to third-party plants. The company's trend EV/EBITDA level demonstrates its market value, with the current mark equal to 5.12.
Comprehensive metric breakdowns and analytics for embecta.com (EMBC)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
EMBC - Net Financial Result|Projected Future Earnings Embecta Corp.|EMBC - Price to Earnings Ratio|Forward P/E Multiple Embecta Corp.|EMBC - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Embecta Health|EMBC - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Embecta|EMBC - Earnings per share for the trailing year|Quarterly EPS earnings growth embecta.com|EMBC - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Embecta Corp.
Analysis of all company metrics:Embecta Inc. EMBC
This indicator compares the enterprise value of Embecta Corp. (EMBC), accounting for net debt, against its EBITDA, allowing for an assessment of the business's real value regardless of its debt load. By analyzing the EV/EBITDA ratio from a historical perspective, an investor can see how the stability of sterile manufacturing facilities in the US and Ireland influences the fundamental attractiveness of the shares relative to their market price.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|TNDM (Tandem Diabetes Care, Inc.) - EV/EBITDA Multiple|AxoGen Inc (AXGN) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SIBN|Enterprise Value to EBITDA Ratio Orthofix Corp OFIX|EV/EBITDA Multiple BVS (Bioventus Inc.)|EV/EBITDA Multiple OrthoPediatrics Corp KIDS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|Company Value to EBITDA Autonomix Medical (AMIX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Enterprise Value to EBITDA Ratio Bone Biologics Corp. (BBLG)|EV/EBITDA Multiple AXNX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BIOL (Biolase Inc.)|EV/EBITDA Multiple DYNT (Dynatronics)|Paragon 28 Inc. (FNA) - Company Value to EBITDA|INVO Bio - EV/EBITDA Multiple
